These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3615688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M, Turner SM, Michelson L, Jacob R.
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M, Pini S, Bellantuono C, Wilkinson G.
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J, Insel TR.
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 9. Biological markers in obsessive-compulsive and affective disorders.
    Insel TR, Mueller EA, Gillin JC, Siever LJ, Murphy DL.
    J Psychiatr Res; 1984 Oct; 18(4):407-23. PubMed ID: 6512711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clomipramine: a tricyclic antidepressant effective in obsessive compulsive disorder.
    Kelly MW, Myers CW.
    DICP; 1990 Oct; 24(7-8):739-44. PubMed ID: 2197816
    [Abstract] [Full Text] [Related]

  • 13. Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy.
    Foa EB, Kozak MJ, Steketee GS, McCarthy PR.
    Br J Clin Psychol; 1992 Sep; 31(3):279-92. PubMed ID: 1393157
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A cross-over treatment of obsessive-compulsive neurosis with imipramine and chlorimipramine].
    Lei BS.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Oct; 19(5):275-8. PubMed ID: 3556093
    [No Abstract] [Full Text] [Related]

  • 18. Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.
    Arch Gen Psychiatry; 1991 Aug; 48(8):730-8. PubMed ID: 1883256
    [Abstract] [Full Text] [Related]

  • 19. Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study.
    Montgomery SA, Montgomery DB, Fineberg N.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Aug; 14(5):719-27. PubMed ID: 2293252
    [Abstract] [Full Text] [Related]

  • 20. Imipramine and placebo in the treatment of obsessive-compulsives: their effect on depression and on obsessional symptoms.
    Foa EB, Steketee G, Kozak MJ, Dugger D.
    Psychopharmacol Bull; 1987 Aug; 23(1):8-11. PubMed ID: 3602334
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.